{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:08:32Z","timestamp":1791173312504,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2974,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Merck KGaA, Darmstadt, Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1093\/annonc\/mdr139","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T04:11:59Z","timestamp":1306210319000},"page":"2191-2200","source":"Crossref","is-referenced-by-count":61,"title":["Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines"],"prefix":"10.1016","volume":"22","author":[{"given":"J.","family":"Bernier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.G.","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Homey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Merlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mes\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peyrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr139_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdr139_bb0015","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gregoire","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-717X-3-5","article-title":"Severe skin reaction secondary to concomitant radiotherapy plus cetuximab","volume":"3","author":"Berger","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr139_bb0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.007","article-title":"High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes","volume":"90","author":"Giro","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2007.04.034","article-title":"Acneiform rash secondary to cetuximab plus head and neck radiotherapy [Letter]","volume":"85","author":"Mydin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","article-title":"Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab","volume":"184","author":"Bolke","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1093\/annonc\/mdr139_bb0050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/annonc\/mdq412","article-title":"Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study","volume":"22","author":"Merlano","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0055","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr139_bb0060","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.clon.2008.07.003","article-title":"Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer","volume":"20","author":"Teoh","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1093\/annonc\/mdr139_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/annonc\/mdm400","article-title":"Consensus guidelines for the management of radiation dermatitis and co-existing acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck","volume":"19","author":"Bernier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0075","unstructured":"US Department of Health and Human Services. National Institutes of Health. National Cancer InstituteCommon Terminology Criteria for Adverse Events (CTCAE)28 May 2009 (v4.03: 14 June 2010). http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html (October 2010, date last accessed)"},{"key":"10.1093\/annonc\/mdr139_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1523-1747.2003.12359.x","article-title":"Barrier function of the skin: \u201cla raison d'etre\u201d of the epidermis","volume":"121","author":"Madison","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdr139_bb0085","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","article-title":"The epidermal growth factor receptor system in skin repair and inflammation","volume":"128","author":"Pastore","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdr139_bb0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0095","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jid.2009.336","article-title":"EGFR regulates the expression of keratinocyte-derived granulocyte\/macrophage colony-stimulating factor in vitro and in vivo","volume":"130","author":"Mascia","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdr139_bb0100","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","article-title":"ERK1\/2 regulates epidermal chemokine expression and skin inflammation","volume":"174","author":"Pastore","year":"2005","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdr139_bb0105","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI28422","article-title":"Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor","volume":"116","author":"S\u00f8rensen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdr139_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.2002.20.1.110","article-title":"Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition","volume":"20","author":"Albanell","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(00)01488-7","article-title":"Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation","volume":"49","author":"Harari","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr139_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.soncn.2006.04.004","article-title":"Evidence-based skin care management in radiation therapy","volume":"22","author":"McQuestion","year":"2006","journal-title":"Semin Oncol Nurs"},{"key":"10.1093\/annonc\/mdr139_bb0125","series-title":"Systemic Inflammatory Response Syndrome: A Unifying Concept of Systemic Inflammation","author":"Bone","year":"1997"},{"key":"10.1093\/annonc\/mdr139_bb0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00002820-200212000-00007","article-title":"A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue","volume":"25","author":"Heggie","year":"2002","journal-title":"Cancer Nurs"},{"key":"10.1093\/annonc\/mdr139_bb0135","first-page":"543","article-title":"The effect of aloe vera gel\/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy","volume":"28","author":"Olsen","year":"2001","journal-title":"Oncol Nurs Forum"},{"key":"10.1093\/annonc\/mdr139_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2007.05.063","article-title":"Ultrathin hydrocolloid dressing in skin damaged from alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (G.O.N.O. AlteRCC Italian Trial): in regard to Macmillan et al. (Int J Radiat Oncol Biol Phys 2007;68:864\u2013872)","volume":"69","author":"Russi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr139_bb0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0360-3016(97)00095-3","article-title":"Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation","volume":"38","author":"Burch","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr139_bb0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/02841869609100721","article-title":"Skin treatment with bepanthen cream versus no cream during radiotherapy\u2014a randomized controlled trial","volume":"35","author":"L\u00f8kkevik","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2002.04751.x","article-title":"Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study","volume":"146","author":"Schmuth","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1093\/annonc\/mdr139_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11523-009-0114-0","article-title":"Skin toxicity associated with epidermal growth factor receptor inhibitors","volume":"4","author":"Li","year":"2009","journal-title":"Target Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0165","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2005.04.9148","article-title":"Phase III trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13","volume":"24","author":"Elliott","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0360-3016(93)90958-X","article-title":"A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium","volume":"26","author":"Halperin","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr139_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12094-010-0465-0","article-title":"Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis","volume":"12","author":"Pardo Masferrer","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2004.07.063","article-title":"Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer","volume":"22","author":"Pommier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr139_bb0185","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1148\/radiology.143.3.7079509","article-title":"Prophylaxis of radiation dermatitis with a topical cortisone cream","volume":"143","author":"Potera","year":"1982","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mdr139_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0360-3016(96)00320-3","article-title":"Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity","volume":"36","author":"Williams","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr139_bb0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijrobp.2009.04.066","article-title":"A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck","volume":"77","author":"Buiret","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419377567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419377567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/10\/2191\/13784401\/mdr139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:47:58Z","timestamp":1624438078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419377567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0923753419377567"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr139","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}